NCT00994357

Brief Summary

The purpose of the study is to investigate the effects of Real-time Continuous Glucose Monitoring on severe complications to pregnancy in women with diabetes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
154

participants targeted

Target at P50-P75 for not_applicable diabetes

Timeline
Completed

Started Feb 2009

Typical duration for not_applicable diabetes

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 13, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 14, 2009

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

May 9, 2012

Status Verified

May 1, 2012

Enrollment Period

2.7 years

First QC Date

October 13, 2009

Last Update Submit

May 8, 2012

Conditions

Keywords

Real-time Continuous Glucose MonitoringMacrosomia

Outcome Measures

Primary Outcomes (1)

  • Prevalence of LGA in children of diabetic women.

    Obtained shortly after birth

Secondary Outcomes (4)

  • Metabolic control in terms of HbA1c, blood sugar measurements and the occurence of severe hypoglycemia in pregnant diabetic patients.

    During pregnancy

  • Quality of life, locus of control and anxiety and depression scores in pregnant diabetic patients.

    During pregnancy

  • Neonatal disease such as neonatal hypoglycemia, respiratory distress and the occurrence of malformations in children of diabetic mothers.

    Shortly after birth

  • The occurrence of low grade inflammation and endothelial dysfunction in pregnant women with diabetes.

    During pregnancy

Study Arms (2)

Real-time Continuous Glucose Monitoring

EXPERIMENTAL

Real-time Continuous Glucose Monitoring at five times for up to 6 days during pregnancy, and during delivery, in addition to standard monitoring and treatment.

Device: Real-time CGM

Control group

ACTIVE COMPARATOR

Standard monitoring and treatment of diabetic patients during pregnancy.

Other: Standard care

Interventions

See previous description.

Real-time Continuous Glucose Monitoring

See text.

Control group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregestational diabetes, type 1 or type 2
  • Single intrauterine pregnancy
  • At least 18 years old
  • Informed consent

You may not qualify if:

  • Mental disorders
  • Language barriere
  • Gemelli
  • Diabetic nephropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Cordua S, Secher AL, Ringholm L, Damm P, Mathiesen ER. Real-time continuous glucose monitoring during labour and delivery in women with Type 1 diabetes - observations from a randomized controlled trial. Diabet Med. 2013 Nov;30(11):1374-81. doi: 10.1111/dme.12246. Epub 2013 Jul 26.

  • Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013 Jul;36(7):1877-83. doi: 10.2337/dc12-2360. Epub 2013 Jan 24.

MeSH Terms

Conditions

Diabetes Mellitus

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Elisabeth R Mathiesen, M.D.

    Center for Pregnant Women with Diabetes, Copenhagen University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 13, 2009

First Posted

October 14, 2009

Study Start

February 1, 2009

Primary Completion

October 1, 2011

Study Completion

May 1, 2012

Last Updated

May 9, 2012

Record last verified: 2012-05